Pulmonary Hypertension: From Molecular and Cellular Mechanisms to Therapeutic Opportunities
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 173
Special Issue Editor
Interests: pulmonary hypertension; asthma; chronic obstructive pulmonary disease; inflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are thrilled to present a Special Issue in Cells dedicated to the captivating realm of "Pulmonary Hypertension: From Molecular and Cellular Mechanisms to Therapeutic Opportunities". Pulmonary hypertension, a complex disorder characterized by elevated blood pressure within the pulmonary vasculature, poses a significant challenge to both researchers and clinicians. This Special Issue aims to foster a deeper understanding of the intricacies underlying pulmonary hypertension while exploring innovative avenues for therapeutic intervention.
Pulmonary hypertension is driven by intricate molecular and cellular mechanisms that orchestrate vascular remodeling, ultimately leading to impaired cardiac function. This Special Issue seeks to illuminate the pathways and factors that underlie the condition's onset, progression, and heterogeneity. Moreover, we delve into emerging diagnostic strategies, from advanced imaging techniques to biomarker profiling, aiming to facilitate early detection and intervention.
Beyond understanding the mechanisms, this Special Issue turns its gaze toward therapeutic opportunities. From novel pharmacological agents targeting specific pathways to revolutionary cell-based therapies, we aim to showcase cutting-edge research that holds potential for transforming patient care. This issue serves as a platform for researchers to share their findings, engage in scientific dialogue, and collectively shape the future of pulmonary hypertension treatment.
We invite researchers, scholars, and experts from around the world to contribute their valuable insights to this Special Issue. By presenting your work on molecular mechanisms, cellular interactions, diagnostic advancements, or innovative therapeutic strategies, you have the opportunity to contribute to advancing our understanding of pulmonary hypertension and its management.
We look forward to your contributions.
Prof. Dr. Yong-Xiao Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary hypertension
- molecular mechanism
- cellular responses, signaling mechanisms
- novel diagnosis and treatments
